Subacute leukencephalopathy after low-dose intrathecal methotrexate in an adolescent heterozygous for the MTHFR C677T polymorphism

Medical and Pediatric Oncology

Volumn 40, Issue 1, 2003, Pages 48-50

  Strunk, Tobias ^a,b   Gottschalk, Stefan ^a   Goepel, Wolfgang ^a   Bucsky, Peter ^a   Schultz, Christian ^a  

^a Department of Radiology University of Luebeck Medical School   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Acute lymphoblastic leukemia; MTHFR polymorphism; MTX encephalopathy

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DEXAMETHASONE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AMNESIA; ARTICLE; CASE REPORT; DNA POLYMORPHISM; DYSARTHRIA; HEMIPARESIS; HETEROZYGOSITY; HUMAN; LEUKOENCEPHALOPATHY; LOW DRUG DOSE; MALE; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SHORT TERM MEMORY; SIDE EFFECT; VERBAL BEHAVIOR;

EID: 0037210184     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10192     Document Type: Article

References (9)

1. Keime-Guibert F, Napolitano M, Delattre JY. Neurological complications of radiotherapy and chemotherapy. J Neurol 1998;245:695-708.
2. Asato R, Akiyama Y, Ito M, et al. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate. Cancer 1992;70:1997-2004.
3. Posner JB. Side effects of chemotherapy. In: Posner JB, editor. Neurologic Complications of Cancer. Philadelphia: F.A. Davis Company; 1995. p 282-310.
4. Winick NJ, Bowman WP, Kamen BA, et al. Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia. J Natl Cancer Inst 1992;84:252-256.
5. Schweitzer DH, Edelbroek PM, de Wolff FA, et al. Acute reversible neurotoxicity after intrathecal low-dose methotrexate. Eur J Cancer 1991;27:219-220.
6. Wiemels JL, Smith RN, Taylor GM, et al. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 2001;98:4004-4009.
7. Skibola CF, Smith MT, Kane E, et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 1999;96:12810-12815.
8. Relling MV, Dervieux T. Pharmacogenetics and cancer therapy. Nat Cancer Rev 2001;1:99-108.
9. Ulrich AM, Yasui Y, Storb R, et al. Pharmocogenetics of methotrexate: Toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood 2001;98:231-234.